EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

O uso indiscriminado de agonistas do GLP-1 (semaglutida e tirzepatida) para o emagrecimento e o papel do farmacêutico na promoção do uso racional

Danilo Conceição Silva, Vitória Caroline Anjos da Conceição, Laine Oliveira de Jesus, Maria Jocilene de Jesus Lima, Lorena Silva Matos Andrade

Revista ft · 16.05.2026 · 30 (158) · 01-19

DOI: 10.69849/d1av6113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista ft, online erschienen am 16.05.2026. Verfasst von Danilo Conceição Silva und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity is a multifactorial chronic disease and a public health challenge, which has driven the use of pharmacological strategies such as GLP-1 receptor agonists, specifically semaglutide and tirzepatide. This integrative literature review analyzed studies published between 2018 and 2025 to evaluate the therapeutic application, risks, and the pharmacist's role in this scenario. The results indicate that irrational use increases the risk of serious adverse events, such as gastroparesis, pancreatitis, and biliary complications. Furthermore, it evidenced that high aesthetic demand, driven by unrealistic beauty standards, exacerbates socioeconomic inequalities, as access is mediated by income. This process transforms essential medicines into restricted consumer items, harming patients with real clinical needs. It is concluded that the pharmacist's performance is essential in promoting rational use, acting in health education, monitoring adverse reactions, and ensuring patient safety in the face of the medicalization of aesthetics.

Zitieren

APA

Silva, D. C., Conceição, V. C. A. D., Jesus, L. O. D., Lima, M. J. D. J., & Andrade, L. S. M. (2026). O uso indiscriminado de agonistas do GLP-1 (semaglutida e tirzepatida) para o emagrecimento e o papel do farmacêutico na promoção do uso racional. Revista ft, 30(158), 01-19. https://doi.org/10.69849/d1av6113

Vancouver

Silva DC, Conceição VCAD, Jesus LOD, Lima MJDJ, Andrade LSM. O uso indiscriminado de agonistas do GLP-1 (semaglutida e tirzepatida) para o emagrecimento e o papel do farmacêutico na promoção do uso racional. Revista ft. 2026;30(158):01-19. doi:10.69849/d1av6113

BibTeX
@article{Silva2026,
  author = {Silva, Danilo Conceição and Conceição, Vitória Caroline Anjos da and Jesus, Laine Oliveira de and Lima, Maria Jocilene de Jesus and Andrade, Lorena Silva Matos},
  title = {O uso indiscriminado de agonistas do GLP-1 (semaglutida e tirzepatida) para o emagrecimento e o papel do farmacêutico na promoção do uso racional},
  journal = {Revista ft},
  year = {2026},
  volume = {30},
  number = {158},
  pages = {01--19},
  doi = {10.69849/d1av6113}
}
Kostenlos starten →